Cardiol Therapeutics Inc. - Form 6-K Filing

This filing is a report from Cardiol Therapeutics Inc. for April 2026, filed as a Form 6-K. The report includes a Notice of Meeting and Record Date for the Annual General Meeting of securityholders, scheduled for June 24, 2026. The record date for notice, voting, and beneficial ownership determination is May 7, 2026. The Class A Common securities are entitled to vote, with ISIN CA14161Y2006. The company will pay for the delivery of proxy materials to OBOs and will use Notice and Access for both beneficial and registered holders. The filing was made by Odyssey Trust Company as agent for Cardiol Therapeutics Inc.